Oruka Therapeutics (ORKA) Non-cash Items (2011 - 2026)

Oruka Therapeutics' Non-cash Items history runs 16 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Non-cash Items fell 73.0% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 73.0% YoY), while the FY2025 annual figure was $972898.0, down 93.71% from the prior year.
• Non-cash Items was $1.3 million for Q1 2026 at Oruka Therapeutics, down from $70.0 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $70.0 million in Q4 2025 to a low of $18000.0 in Q4 2022.
• Historically, Non-cash Items has averaged $7.8 million across 5 years, with a median of $502517.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Non-cash Items sank 99.05% in 2022, then soared 4449.71% in 2025.
• A 5-year view of Non-cash Items shows it stood at $18000.0 in 2022, then surged by 1938.89% to $367000.0 in 2023, then soared by 4115.26% to $15.5 million in 2024, then jumped by 352.27% to $70.0 million in 2025, then plunged by 98.18% to $1.3 million in 2026.
• The last three Non-cash Items figures came in at $1.3 million (Q1 2026), $70.0 million (Q4 2025), and $30.9 million (Q3 2025), per Business Quant data.